Literature DB >> 28445656

Learning What We Didn't Know - The SPRINT Data Analysis Challenge.

Nancy S Burns1, Pamela W Miller1.   

Abstract

Mesh：

Year:  2017        PMID： 28445656     DOI： 10.1056/NEJMp1705323

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Impaired Fasting Glucose and Chronic Kidney Disease, Albuminuria, or Worsening Kidney Function: a Secondary Analysis of the SPRINT.

Authors:  Miguel Bigotte Vieira; João Sérgio Neves; Lia Leitão; Rute Baeta Baptista; Rita Magriço; Catarina Viegas Dias; Ana Oliveira; Davide Carvalho; Finnian R Mc Causland
Journal:  J Clin Endocrinol Metab       Date:  2019-05-07       Impact factor: 5.958

2.  Availability and Use of Shared Data From Cardiometabolic Clinical Trials.

Authors:  Muthiah Vaduganathan; Amulya Nagarur; Arman Qamar; Ravi B Patel; Ann Marie Navar; Eric D Peterson; Deepak L Bhatt; Gregg C Fonarow; Clyde W Yancy; Javed Butler
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

3.  Feasibility, Process, and Outcomes of Cardiovascular Clinical Trial Data Sharing: A Reproduction Analysis of the SMART-AF Trial.

Authors:  Hawkins C Gay; Abigail S Baldridge; Mark D Huffman
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

Review 4.  Characteristics of available studies and dissemination of research using major clinical data sharing platforms.

Authors:  Enrique Vazquez; Henri Gouraud; Florian Naudet; Cary P Gross; Harlan M Krumholz; Joseph S Ross; Joshua D Wallach
Journal:  Clin Trials       Date:  2021-08-18       Impact factor: 2.486

5.  BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.

Authors:  Rita Magriço; Miguel Bigotte Vieira; Catarina Viegas Dias; Lia Leitão; João Sérgio Neves
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-03       Impact factor: 8.237

6.  Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.

Authors:  Yan Gong; Steven M Smith; Eileen M Handberg; Carl J Pepine; Rhonda M Cooper-DeHoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-13       Impact factor: 3.738

7.  Prognostic importance of long-term SBP variability in high-risk hypertension.

Authors:  Rita Del Pinto; Davide Pietropaoli; Mirela Dobre; Claudio Ferri
Journal:  J Hypertens       Date:  2020-11       Impact factor: 4.776

8.  Incremental effects of antihypertensive drugs: instrumental variable analysis.

Authors:  Adam A Markovitz; Jacob A Mack; Brahmajee K Nallamothu; John Z Ayanian; Andrew M Ryan
Journal:  BMJ       Date:  2017-12-22

9.  Effect of additional antihypertensive medications in patients with high-risk hypertension: a post hoc analysis of the SPRINT (Systolic Blood Pressure Intervention Trial) database.

Authors:  Lee S Nguyen
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-15       Impact factor: 3.738

10.  Sharing and reuse of individual participant data from clinical trials: principles and recommendations.

Authors:  Christian Ohmann; Rita Banzi; Steve Canham; Serena Battaglia; Mihaela Matei; Christopher Ariyo; Lauren Becnel; Barbara Bierer; Sarion Bowers; Luca Clivio; Monica Dias; Christiane Druml; Hélène Faure; Martin Fenner; Jose Galvez; Davina Ghersi; Christian Gluud; Trish Groves; Paul Houston; Ghassan Karam; Dipak Kalra; Rachel L Knowles; Karmela Krleža-Jerić; Christine Kubiak; Wolfgang Kuchinke; Rebecca Kush; Ari Lukkarinen; Pedro Silverio Marques; Andrew Newbigging; Jennifer O'Callaghan; Philippe Ravaud; Irene Schlünder; Daniel Shanahan; Helmut Sitter; Dylan Spalding; Catrin Tudur-Smith; Peter van Reusel; Evert-Ben van Veen; Gerben Rienk Visser; Julia Wilson; Jacques Demotes-Mainard
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.